UCHL3
UCHL3 (ubiquitin C-terminal hydrolase L3) is a cytoplasmic deubiquitinating enzyme and thiol protease of the peptidase C12 family. It controls cellular ubiquitin levels by processing ubiquitin precursors and ubiquitinated proteins, and it also acts on NEDD8. Browse Assay Genie's current range of UCHL3 research reagents below, or read on for the biology behind the target.
UCHL3 is a deubiquitinating enzyme (DUB) that regulates the pool of cellular ubiquitin. As a thiol protease, it recognises and hydrolyses a peptide bond at the C-terminal glycine of either ubiquitin or NEDD8. It processes ubiquitin precursors and ubiquitinated proteins, and the RefSeq summary describes it as likely to hydrolyse the ubiquitinyl-N-epsilon amide bond of ubiquitinated proteins so that ubiquitin is regenerated for another catalytic cycle. It shows a ten-fold preference for Arg and Lys at position P3'' and prefers 'Lys-48'-linked ubiquitin chains.
Beyond ubiquitin recycling, UniProt annotates several specific roles for UCHL3. It can hydrolyse UBB(+1), a mutated form of ubiquitin that the proteasome does not degrade effectively and which is associated with neurodegenerative disorders. In DNA repair by homologous recombination, UCHL3 deubiquitinates RAD51 after DNA damage, promoting the interaction between RAD51 and BRCA2. It also deubiquitinates ENAC in apical compartments, regulating apical membrane recycling. It indirectly increases phosphorylation of IGFIR, AKT and FOXO1, promoting insulin signalling and insulin-induced adipogenesis. It is required for stress-response maintenance of retinal, skeletal muscle and germ cells, and may be involved in working memory.
The UCHL3 gene encodes a member of the peptidase C12 family and belongs to the HGNC group of ubiquitin C-terminal hydrolases. The enzyme is classed as EC 3.4.19.12, and alternative splicing is reported to give multiple transcript variants encoding different protein isoforms. Earlier nomenclature named it ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase). Mouse and rat both have a Uchl3 ortholog. Related family member UCH-L1 and the more distant UCHL5 are also studied in ubiquitin biology.
UCHL3 hydrolyses ubiquitin precursors and ubiquitinated proteins, so it is studied for how cells maintain free ubiquitin levels.
UCHL3 deubiquitinates RAD51 after DNA damage and promotes its interaction with BRCA2 in homologous recombination.
UCHL3 indirectly raises phosphorylation of IGFIR, AKT and FOXO1, promoting insulin signalling and insulin-induced adipogenesis.
UCHL3 can hydrolyse UBB(+1) and is required for retinal, skeletal muscle and germ cell maintenance under stress.
UCHL3 is a deubiquitinating thiol protease that cleaves at the C-terminal glycine of ubiquitin or NEDD8. It processes ubiquitin precursors and ubiquitinated proteins, prefers 'Lys-48'-linked chains, and deubiquitinates substrates such as RAD51 and ENAC, thereby helping control cellular ubiquitin levels.
The HGNC full name is ubiquitin C-terminal hydrolase L3, and UniProt calls it ubiquitin carboxyl-terminal hydrolase isozyme L3. A previous name was ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase). Alternative splicing gives multiple transcript variants encoding different isoforms. No other aliases are listed.
Yes. Mouse and rat each have an ortholog named Uchl3, so the protein can be studied in common rodent models. UCHL3 is linked to neurodegeneration through its activity on UBB(+1). Check the datasheet of any product for its validated reactivity.
Other ubiquitin C-terminal hydrolases and deubiquitinating enzymes with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P15374; product specifications from Assay Genie datasheets.